NICE data highlight hypertension management needs:
This article was originally published in Clinica
Updated guidance on the management of hypertension, issued by the UK's National Institute for Health and Clinical Excellence (NICE) today (June 28), focuses on the pharmacological treatment of the condition, adding nothing new to current policy on diagnosis and monitoring. However, data on the UK's incidence of the condition reveal that around 40% of the adult population are hypertensive - the proportion rises with age - and that inadequate management of the condition is the single greatest risk factor in stroke, coronary heart disease and chronic renal failure.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”